Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT06706414
PHASE1/PHASE2

NT-NOA - Novel Treatment of Some Men With Non-Obstructive Azoospermia

Sponsor: Martin Blomberg Jensen

View on ClinicalTrials.gov

Summary

This clinical interventional study aims to assess whether treatment with denosumab in combination with letrozole can improve sperm production in infertile men with non-obstructive azoospermia selected by serum anti-mullerian hormone (AMH) as a positive predictive biomarker.

Official title: Novel Treatment of Some Men With Non-Obstructive Azoospermia (NT-NOA): A Clinical Interventional Study

Key Details

Gender

MALE

Age Range

18 Years - 60 Years

Study Type

INTERVENTIONAL

Enrollment

16

Start Date

2025-03-01

Completion Date

2026-08

Last Updated

2025-12-01

Healthy Volunteers

Yes

Interventions

DRUG

Denosumab (Prolia)

Subcutaneous injection with 60 mg Denosumab once

DRUG

Letrozole (Aromatase Inhibitors)

Letrozole oral tablet 2.5 mg once daily

Locations (1)

Division of Translational Endocrinology, Department of Endocrinology and Internal Medicine, Herlev and Gentofte Hospital

Herlev, Denmark